Multiple myeloma biology: lessons from the 5TMM models

被引:88
作者
Vanderkerken, K
Asosingh, K
Croucher, P
Van Camp, B
机构
[1] Free Univ Brussels, Dept Hematol & Immunol, B-1090 Brussels, Belgium
[2] Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Oxford OX3 7LD, England
关键词
D O I
10.1034/j.1600-065X.2003.00035.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple myeloma (MM) is a B cell neoplasm characterized by the monoclonal proliferation of plasma cells in the bone marrow, the development of osteolytic lesions and the induction of angiogenesis. These different processes require three-dimensional interactions, with both humoral and cellular contacts. The 5TMM models are suitable models to study these interactions. These murine models originate from spontaneously developed myeloma in elderly mice, which are propagated by in vivo transfer of the myeloma cells into young syngeneic mice. In this review we report on studies performed in the 5TMM models with special emphasis on the homing of the myeloma cells, the characterization of the migrating and proliferating clone and the identification of the isotype switch variants. The bone marrow microenvironment was further targeted with osteoprotegerin (OPG) to block the RANK/RANKL/OPG system and with potent bisphosphonates. Both treatments resulted in a significant protection against myeloma-associated bone disease, and they decreased myeloma disease, as evidenced by a lower tumor load and an increased survival of the mice. These different studies demonstrate the strength of these models, not only in unraveling basic biological processes but also in the testing of potentially new therapeutic targets.
引用
收藏
页码:196 / 206
页数:11
相关论文
共 65 条
[1]  
Aoudjit F, 1998, J IMMUNOL, V160, P2967
[2]   Selective in vivo growth of lymphocyte function-associated antigen-1-positive murine myeloma cells: Involvement of function-associated antigen-1-mediated homotypic cell-cell adhesion [J].
Asosingh, K ;
Vankerkhove, V ;
Van Riet, I ;
Van Camp, B ;
Vanderkerken, K .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (01) :48-55
[3]   Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma [J].
Asosingh, K ;
Menu, E ;
Van Valckenborgh, E ;
Vande Broek, I ;
Van Riet, I ;
Van Camp, B ;
Vanderkerken, K .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) :583-591
[4]   In vivo homing and differentiation characteristics of mature (CD45-) and immature (CD45+) 5T multiple myeloma cells [J].
Asosingh, K ;
De Raeve, H ;
Croucher, P ;
Goes, E ;
Van Riet, I ;
Van Camp, B ;
Vanderkerken, K .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (01) :77-84
[5]  
Asosingh K, 2001, CANCER RES, V61, P2862
[6]  
Asosingh K, 2000, Hematol J, V1, P351, DOI 10.1038/sj.thj.6200052
[7]  
Asosingh K, 2000, CANCER RES, V60, P3096
[8]  
ASOSINGH K, 2003, IN PRESS BLOOD
[9]   Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation [J].
Avet-Loiseau, H ;
Facon, T ;
Grosbois, B ;
Magrangeas, F ;
Rapp, MJ ;
Harousseau, JL ;
Minvielle, S ;
Bataille, R .
BLOOD, 2002, 99 (06) :2185-2191
[10]   THE CLONOGENIC PRECURSOR CELL IN MULTIPLE-MYELOMA [J].
BAKKUS, MHC ;
VANRIET, I ;
DEGREEF, C ;
VANCAMP, B ;
THIELEMANS, K .
LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) :221-229